	Le Coût Des Ventes		Date
Acadia Pharmaceuticals	USD 26.22M	4.58M	2025-12
Agios Pharmaceuticals	USD 1.88M	199K	2025-12
Akebia Therapeutics	USD 8.13M	2.41M	2025-03
Alnylam Pharmaceuticals	USD 267.72M	67.57M	2025-12
Anika Therapeutics	USD 11.49M	35.48M	2025-03
AstraZeneca	USD 3.27B	471M	2025-12
Bristol-Myers Squibb	USD 4.92B	657M	2025-12
Eli Lilly	USD 3.37B	363.7M	2025-12
Esperion Therapeutics	USD 51.63M	22.2M	2024-09
Halozyme Therapeutics	USD 102.15M	29.14M	2025-12
Heron Therapeutics	USD 9.46M	1.61M	2024-09
Insmed	USD 46.16M	15.25M	2025-12
J&J	USD 7.97B	689M	2025-12
Lexicon Pharmaceuticals	USD 17.81M	3.41M	2024-06
Ligand Pharmaceuticals	USD 11.9M	733K	2025-09
Merck	USD 3.32B	531M	2025-12
Minerva Neurosciences	386K	31K	2024-06
Moderna	USD 452M	245M	2025-12
Novartis	USD 3.54B	216M	2025-09
Pfizer	USD 6.29B	2.12B	2025-12
PTC Therapeutics	USD 16.3M	7.02M	2025-12
Puma Biotechnology	USD 29.1M	18.44M	2024-09
Sangamo BioSciences	2.42M	1.11M	2024-06
Sanofi	EUR 4.29B	421M	2025-12
Takeda	JPY 401.15B	184.07B	2025-12
Teva Pharmaceutical Industries	USD 2.06B	120M	2025-12
Ultragenyx Pharmaceutical	USD 29M	1.01M	2025-12
Vanda Pharmaceuticals	USD 198.77M	151.12M	2024-12
Veracyte	USD 39.28M	1.93M	2025-12

Vanda Pharmaceuticals Le Coût Des Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.